Alginate-based Reflux Suppressant and Magnesium-aluminium Antacid Gel for Treatment of Heartburn in Pregnancy

• Status: Completed
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study evaluates the efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy. Half of the participants will receive alginate-based reflux suppressant, while the other half will receive magnesium-aluminium antacid gel.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Chulalongkorn University
• Treatments: Alginic acid; Antacids; Anti-Ulcer Agents

Criteria

Inclusion Criteria:

• Pregnant women gestational age less than 36 weeks with heartburn

Exclusion Criteria:

• Having medical disease that contraindicated to use study drug

• Allergic to alginate-based reflux suppressant and magnesium-aluminium antacid gel